Physician profile
Daniel E Schneider
NPI 1861786261
$2,545.80
in general payments reported to CMS, 2019-2025
27 companies · $238 in 2025
The $238 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $113 · 2020: $62.93 · 2021: $159 · 2022: $1,473 · 2023: $386 · 2024: $115 · 2025: $238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $674 · Education: $65.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $673.74 |
| Education | $65.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Valencia Technologies Corporation | $1,334.06 | 2022-2023 | Ecoin Device Kit |
| Convatec INC. | $282.85 | 2021-2024 | |
| Astellas Pharma US INC | $271.59 | 2019-2023 | Myrbetriq |
| Abbvie INC. | $94.39 | 2019-2023 | Lupron Depot, Botox |
| Olympus America INC. | $54.02 | 2025 | Itind System |
| Pfizer INC. | $45.69 | 2025 | |
| Calyxo, INC. | $44.74 | 2024-2025 | Cvac Aspiration System |
| Endo Pharmaceuticals INC. | $36.29 | 2023-2024 | Edex, Aveed, Xiaflex |
| Boston Scientific Corporation | $36.06 | 2020-2024 | Spaceoar Vue System - 10ml |
| Janssen Biotech, INC. | $27.59 | 2025 | Erleada |
| Novartis Pharmaceuticals Corporation | $26.87 | 2025 | |
| Karl Storz Endoscopy-America | $25.90 | 2020 | |
| Welch Allyn | $24.38 | 2021 | |
| 180 Medical, INC. | $24.08 | 2023 | Gentlecath Glide |
| Sumitomo Pharma America, INC. | $24.02 | 2025 | Orgovyx |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $22.95 | 2025 | Xiaflex, Edex, Aveed |
| Progenics Pharmaceuticals, INC. | $21.21 | 2023 | Pylarify |
| Merck Sharp & Dohme LLC | $19.55 | 2023 | Bridion |
| Tolmar, INC. | $19.28 | 2025 | Jatenzo |
| Axonics, INC. | $18.81 | 2022 | |
| Coloplast Corp | $18.22 | 2023 | Speedicath |
| Urogen Pharma, INC. | $16.58 | 2024 | |
| Ethicon US, LLC | $16.03 | 2019 | |
| Rochester Medical Corporation | $14.89 | 2019 | |
| Chiesi USA, INC. | $13.99 | 2022 | |
| Merz North America, INC. | $11.76 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Schneider listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.